Sign in

CIK 0001124105

  • Accelerated filer
  • Smaller reporting company

GYRE THERAPEUTICS, INC.

Sign in to watch
Ticker
GYRE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562020050
Phone
+1 858-284-0115
Business address
12730 HIGH BLUFF DRIVE, SUITE 250, SAN DIEGO, CA, 92130
Former names
CATALYST BIOSCIENCES, INC., TARGACEPT INC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-08 Luo Ying Chief Executive Officer Grant or award · Stock Option (Right to Buy) +120,000 120,000
2026-05-06 Luo Ying Chief Executive Officer Sale 10b5-1 −10,136 $8.04 $81K 2,565,226
2026-05-05 Luo Ying Chief Executive Officer Sale 10b5-1 −179 $8.01 $1K 2,575,362
2024-08-14 Luo Ying Director Grant or award · Stock Option (Right to Buy) +26,000 26,000
2023-11-20 Luo Ying Director Grant or award · Stock Option (Right to Buy) +3,350,897 3,350,897
2023-11-20 Luo Ying Director Grant or award · Stock Option (Right to Buy) +2,262,755 2,262,755
2023-10-31 Luo Ying Director Grant or award · Stock Option (Right to Buy) +1,866 1,866
2023-10-30 Luo Ying Director Other acquisition +2,840,376 2,840,376

Page 1 of 1 · 8 trades